MedPath

Art Therapy QEEG Study for Service Members with a Traumatic Brain Injury and Posttraumatic Stress Symptoms

Not Applicable
Completed
Conditions
Posttraumatic Stress Disorder
Anger
Combat and Operational Stress Reaction
Combat Stress Disorders
Military Family
Post-Traumatic Headache
TBI (Traumatic Brain Injury)
MTBI - Mild Traumatic Brain Injury
Headache
Eating Disorders
Interventions
Behavioral: Art Therapy
Registration Number
NCT04776304
Lead Sponsor
Walter Reed National Military Medical Center
Brief Summary

Service members and/or recently separated veterans with post traumatic stress symptoms and mild traumatic brain injury may participate in 8 sessions including 2 sessions including interviews and questionnaires as well as 6 sessions of art therapy. In the art therapy, participants will be provided with a blank paper mache mask template and invited to alter the mask however they wish using a variety of art materials. The therapist will use the art-making process and culminating product to aid in self-reflection, reframe negative thoughts and feelings, and work through traumatic content. Prior to the session start participants will get set up with a mobile qEEG (worn like a hat and backpack). The qEEG will measure brain activity in a non-invasive way throughout the art therapy session to improve understanding of brain activity during the art therapy process.

Detailed Description

This is a pilot, interventional clinical trial in which all 9 service members with comorbid PTSD and mTBI participate in 8 sessions (1 baseline session of interviews and questionnaires, 6 sessions of art therapy, and 1 final session of interviews and questionnaires). Participants must have significant posttraumatic stress symptoms and a history of mild traumatic brain injury. Target enrollment is 9 active duty service members or recently separated veterans, aged 18-64 with no prior art therapy exposure, at the NICoE at Walter Reed National Military Medical Center in Bethesda, MD.

Background: Posttraumatic stress disorder (PTSD) and mild traumatic brain injury (mTBI) are persistent and frequently comorbid complications of combat that remain a challenge to healthcare providers. In these complex cases, traditional treatments often fail to provide complete relief from symptoms associated with posttraumatic stress (PTS), anxiety, and depression, leading the military healthcare system to look towards complementary and integrative treatments. Art therapy is one promising intervention that helps service members (SMs) develop a "visual voice," using imagery, symbolism, and metaphor to externalize emotions and experiences that they may not be able to express in words. The standardized, integrative mental health and human services approach of the art therapy program at the NICoE utilizes a mask-making directive to explore thoughts, feelings, and experiences of combat and self-understanding. This process is especially relevant to SMs with PTS symptoms who often remember their trauma as an incoherent, fragmented memory that is often predominantly sensory in nature. NICoE researchers have provided preliminary evidence suggesting associations between recurring art themes represented within the masks and individual BH symptoms; yet, the neurobiological mechanisms underlying this therapeutic technique remain obscure. To date, there have been few studies using neuroimaging techniques to investigate brain network changes during art creation. Studies have utilized electroencephalography (EEG) and functional near infrared spectroscopy (fNIRS) during art creation but not within the context of art therapy. Mobile, quantitative EEG allows for real time data capture that could minimize interference of neuroimaging during the therapeutic process and provide insight into the neurological mechanisms underlying art therapy.

Study design and procedures: Participants will be provided with a blank paper mache mask template and invited to alter the mask however they wish using a variety of art materials. The therapist will use the art-making process and culminating product to aid in self-reflection, reframe negative thoughts and feelings, and work through traumatic content. Prior to the session start participants will get set up with the mobile qEEG. The qEEG will be segmented into a pre-art therapy session resting state, prompt-specific tasks during the art therapy session, and a post-art therapy session resting state.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
2
Inclusion Criteria
  • Active duty service member or recently separated veteran (within the past 5 years)
  • DEERs eligible
  • Significant posttraumatic stress symptoms
  • History of mild traumatic brain injury
  • Aged 18-64
Exclusion Criteria
  • Previous art therapy exposure
  • Moderate, severe, or penetrating TBI history
  • History of a psychotic disorder, bipolar disorder, or active suicidal or homicidal ideation
  • Unable to provide informed consent

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
qEEG Art TherapyArt TherapyParticipants will receive art therapy while a noninvasive, mobile qEEG measures brain activity. There is no comparison as this is an exploratory pilot study.
Primary Outcome Measures
NameTimeMethod
The primary outcome measure is an analysis of qEEG session data.during the intervention Session 6 (Week 7)

The primary outcome measure is an analysis of qEEG session data, which will include regional and global power across the following frequency bands: delta (1-4 Hz), theta (4-7 Hz), alpha (8-13 Hz), beta (13- 30 Hz), and gamma (\>30 Hz); global interhemispheric coherence; and regional coherence between pairs of sensor locations. Global/regional power (units: micro-Volts-squared per Hz (uV2/Hz) Interhemispheric coherence (units coherence) Regional coherence (units coherence)

Secondary Outcome Measures
NameTimeMethod
TAS-20baseline (pre-intervention) and immediately after the intervention; within a period of 8 weeks

The Toronto Alexithymia Scale

CAPS-5baseline (pre-intervention) and immediately after the intervention; within a period of 8 weeks

Clinician-Administered PTSD Scale for DSM-5

AIQbaseline (pre-intervention) and immediately after the intervention; within a period of 8 weeks

Aspects of Identity Questionnaire

SUD Scoresbaseline (pre-intervention) and immediately after the intervention; within a period of 8 weeks

Subjective Units of Distress

GAD-7baseline (pre-intervention) and immediately after the intervention; within a period of 8 weeks

General Anxiety Disorder Questionnaire

PHQ-9baseline (pre-intervention) and immediately after the intervention; within a period of 8 weeks

Patient Health Questionnaire for depression symptoms

PCL-5baseline (pre-intervention) and immediately after the intervention; within a period of 8 weeks

Post Traumatic Stress Symptom Questionnaire

NSIbaseline (pre-intervention) and immediately after the intervention; within a period of 8 weeks

Neurological Symptom Inventory

PGICbaseline (pre-intervention) and immediately after the intervention; within a period of 8 weeks

General Impression of Change

PHQ-15baseline (pre-intervention) and immediately after the intervention; within a period of 8 weeks

Patient Health Questionnaire for somatic symptoms

Trial Locations

Locations (1)

National Intrepid Center of Excellence at Walter Reed National Military Medical Center

🇺🇸

Bethesda, Maryland, United States

© Copyright 2025. All Rights Reserved by MedPath